Showing results (71-80 of 90) with videos related to

Sort By:
Pageof 9
The Journal of Pathology|May 4, 2023
Fusion with type 2 macrophages induces melanoma cell heterogeneity that potentiates immunological escape from cytotoxic T lymphocytesTomoyuki Minowa, Yoshihiko Hirohashi, Kenji Murata, et al.
Experimental and Molecular Pathology|December 4, 2018
Clonal analysis revealed functional heterogeneity in cancer stem-like cell phenotypes in uterine endometrioid adenocarcinomaYuta Tabuchi, Yoshihiko Hirohashi, Shinichi Hashimoto, et al.
Biochemical and Biophysical Research Communications|February 22, 2017
Identification and functional analysis of variants of a cancer/testis antigen LEMD1 in colorectal cancer stem-like cellsRui Takeda, Yoshihiko Hirohashi, Min Shen, et al.
Biochemical and Biophysical Research Communications|February 28, 2017
LY6/PLAUR domain containing 3 has a role in the maintenance of colorectal cancer stem-like cellsLiming Wang, Yoshihiko Hirohashi, Tadashi Ogawa, et al.
Anticancer Research|December 26, 2012
Expression and function of FERMT genes in colon carcinoma cellsKenji Kiriyama, Yoshihiko Hirohashi, Toshihiko Torigoe, et al.
Cancer Science|May 23, 2009
Novel spliced form of a lens protein as a novel lung cancer antigen, Lengsin splicing variant 4Munehide Nakatsugawa, Yoshihiko Hirohashi, Toshihiko Torigoe, et al.
Science Translational Medicine|December 4, 2024
Single-cell profiling of acral melanoma infiltrating lymphocytes reveals a suppressive tumor microenvironmentTomoyuki Minowa, Kenji Murata, Yuka Mizue, et al.
Oncotarget|April 19, 2017
Phosphorylation of HSF1 at serine 326 residue is related to the maintenance of gynecologic cancer stem cells through expression of HSP27Kazuyo Yasuda, Yoshihiko Hirohashi, Tasuku Mariya, et al.
Cancer Science|November 22, 2023
Eribulin is an immune potentiator in breast cancer that upregulates human leukocyte antigen class I expression via the induction of NOD-like receptor family CARD domain-containing 5Asaka Wada, Yoshihiko Hirohashi, Goro Kutomi, et al.
Experimental and Molecular Pathology|October 19, 2010
The feasibility of Cep55/c10orf3 derived peptide vaccine therapy for colorectal carcinomaSatoko Inoda, Rena Morita, Yoshihiko Hirohashi, et al.
Pageof 9